Profile
Ashley Preston currently works at Blossomhill Therapeutics, Inc. as SVP, Head-Regulatory Affairs & Quality Assurance since 2025.
Also holds a position as a Member at Regulatory Affairs Professionals Society.
Formerly worked at Syros Pharmaceuticals, Inc. as Senior Vice President-Global Regulatory Affairs.
Education includes an undergraduate degree from Monash University and a doctorate from RMIT University.
Ashley Preston active positions
| Companies | Position | Start |
|---|---|---|
| BLOSSOMHILL THERAPEUTICS, INC. | General Counsel | 2024-12-31 |
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Corporate Officer/Principal | - |
Former positions of Ashley Preston
| Companies | Position | End |
|---|---|---|
| SYROS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Training of Ashley Preston
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Regulatory Affairs Professionals Society
Regulatory Affairs Professionals Society Miscellaneous Commercial ServicesCommercial Services Operates as NPO that offers healthcare products | Commercial Services |
Monash University
Monash University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RMIT University
RMIT University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Syros Pharmaceuticals, Inc.
Syros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which developing care for the frontline treatment of patients with hematologic malignancies | Health Technology |
Blossomhill Therapeutics, Inc.
Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops therapeutics for oncology and autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Ashley Preston
















